Key result
Sarcopenia is linked to ~3.7-fold higher risk of palliative care indications in heart failure.
Why the study?
To evaluate the need for palliative care in patients with heart failure according to their body composition, specifically obesity and sarcopenia.
Do body composition disorders, specifically sarcopenia and obesity, increase the need for palliative care in patients with heart failure?
Cohort (n=298)
Do body composition disorders, specifically sarcopenia and obesity, increase the need for palliative care in patients with heart failure?
Sarcopenia significantly accelerates functional decline and increases the need for palliative care in patients with heart failure, highlighting the importance of assessing body composition for prognostic stratification.
Answers are grounded in this paper and cite their sources.
Sarcopenia may flag earlier palliative care needs in HF; hypothesis-generating and requires prospective validation before guiding practice.
Aim. To assess the need for palliative care (PC) in patients with heart failure (HF) depending on body composition. Material and methods. The study involved 298 people (115 men and 183 women, mean age — 61 [53;69] years), who were divided into 5 groups depending on body composition — obesity and sarcopenia. Left ventricular ejection fraction, N-terminal pro-brain natriuretic peptide (NT-proBNP) and galectin-3 markers were determined. Kaplan-Meier analysis was performed to assess survival, while Cox regression — the influence of factors. Results. The maximum values of the time of need for PC are characteristic of patients without body composition disorders, and the minimum ones are for patients with sarcopenic obesity. According to Cox regression, a significant increase in hazard ratio for PC indications occurrence was revealed as 22,9 times (p<0,001) with an increase in muscle mass index to body mass index ratio (MMI/BMI) by 1; 1,99 times (p<0,001) with an increase in functional class by 1; 1-1,02 times (p=0,002) with an increase in the galectin level by 1 ng/mL; 0,96 times (p<0,001) with a decrease in the Barthel index by 1; and 3,71 times (p<0,001) in the presence of sarcopenia. Conclusion. The body composition of patients with HF affects the functional activity of the patient, and therefore the need for PC in patients.
No takes yet. Share an insight, caveat, or question.
Shevtsova et al. (2025) conducted a cohort in Heart failure (n=298). Sarcopenia vs. Absence of sarcopenia was evaluated on Occurrence of indications for palliative care (HR 3.71, 95% CI 2.337-5.89, p=<0.001). The presence of sarcopenia significantly increased the risk of developing indications for palliative care in patients with heart failure (HR 3.71).
Synapse has enriched 10 related papers. Consider them for comparative context: